AHA/ACC Joint Committee on Clinical Practice Guidelines Catherine M. Otto, MD, FACC AHA/ACC Joint Committee on Performance Measures Boback Ziaeian, MD, PhD, FACC ...
People who reported spending six or more hours on screens outside of school or work had worse blood pressure, cholesterol and body mass index (BMI) compared with those with more limited screen time, ...
As the new year begins, the landscape of cardiovascular medicine is undergoing a remarkable transformation, driven by groundbreaking technologies and innovative approaches that promise to ...
About 50% of U.S. adults will develop high BP during their lifetime. High BP is the most prevalent and modifiable risk factor for cardiovascular disease and all-cause mortality. The overarching BP ...
We want to hear from you. Tell us what you think here or leave a comment on the app's iTunes or Google Play page. Lipid Manager helps clinicians reduce ASCVD risk by managing patients' LDL-C and ...
The U.S. Food and Drug Administration (FDA) has approved baxdrostat, a first-in-class oral aldosterone synthase inhibitor, as an add-on therapy for hypertension in adults whose blood pressure (BP) is ...
The ACC has issued guidance for the diagnosis and management of acute myocarditis in adult patients, delivering a streamlined decision-making framework that reflects recent advancements in clinical ...
A new clinical guideline released by the ACC and the American Heart Association (AHA) includes new evidence and updated recommendations for managing patients with an ...
The Centers for Medicare and Medicaid Services (CMS) has released the 2026 Medicare Physician Fee Schedule (PFS) final rule. The conversion factor for practitioners participating in a qualified ...
Inflammation plays a central role in the pathogenesis of atherosclerosis and cardiovascular disease. 1 Atherosclerosis in particular is an inflammatory process that involves endothelial dysfunction, ...
A robust body of observational and Mendelian randomization data establishes a causal relationship between elevated Lp(a) and ASCVD, ischemic stroke and calcific aortic valve stenosis (CAVS). 3 A ...
The incidence and prevalence of heart failure with preserved ejection fraction (HFpEF) is increasing, along with the aging population and the ongoing rise in risk factors such as hypertension, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results